@Simonwhite 1 month ago
AstraZeneca trial results
AstraZeneca trial results
i was surprised to see the heart-disease trial results for AstraZeneca fall short like that. do you think the current dip in is a bit of an overreaction or is the pipeline risk actually quite worrying?
@ProduceCut309 1 month ago
The sell-off is understandable, but one trial setback doesn’t necessarily define the company’s long-term outlook or pipeline.
